Schedule Update - effective 1 June 2009 (text extract)

This is the text extract for Schedule Update - effective 1 June 2009, browse documents here.

Pharmaceutical Management Agency

Update

New Zealand Pharmaceutical Schedule

Effective 1 June 2009 Cumulative for May and June 2009. Section H cumulative for April, May and June 2009

Contents

Summary of PHARMAC decisions

EFFECTIVE 1 JUNE 2009 New listings (page 19)

Decreased subsidy (page 22)

μ μ

Increased subsidy (page 22)

4 Pharmaceutical Schedule - Update News

Understanding Tender transitions

When medicines are no longer under patent, other suppliers are able to sell ‘generic’ versions. This allows for competition, often between several suppliers. Tendering for medicines has been a very successful strategy. The company gets sole subsidised supply of the medicine for a fixed term (usually three years), and this security gives the supplier a major incentive to offer us the best price. As well as saving public health money through lower prices, tenders also secure the supply of medicines through a contract. PHARMAC has run a tender every year since 1997, when one product was tendered paracetamol. Twelve years later, nearly half of all subsidised medicines (by volume) are purchased through the tender, and this has generated savings of more than $300 million. These savings are re-invested by funding new medications or widening of access to current medications. In a small market like New Zealand, the tender has also been an important mechanism for securing supply of smallvolume but important medicines through a contract. PHARMAC thinks carefully about which medicines to tender for, and an advisory committee of doctors and pharmacists

assess the bids on clinical and packaging grounds before the tender process is finalised. At the end of each month PHARMAC advises suppliers, pharmacists and wholesalers of the upcoming Tender results to be implemented. This advice is also published on our website. Sometimes there can be confusion about the transition times from one brand of medicine to another. When a new brand is to be awarded sole subsidised supply , there is a 6 months transition period. This is the time from notification to the time that the sole subsidised supply begins. There is some information below to help explain the transition timeframe and the formula PHARMAC uses when implementing a brand change as part of the tendering process. The following example from the Tender results in the 31 March 2009 notification facsimile is used to explain the process:

Pharmaceutical Schedule - Update News

Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule 1. Tenders awarded to pharmaceuticals where at least one other brand is listed – listing for tender winning brand at the tender subsidy will occur on 1 May 2009, reference pricing of non-tender winning brand will occur on 1 July 2009 and Sole Subsidised Supply commences on 1 October 2009. The decisions were as follows:

Chemical Name Presentation; Pack size and type Current Subsidy New tender subsidy $23.30 (500 tablets) Sole supply brand (Supplier) Apo-Terazosin (Apotex) Brands affected by reference pricing and delisting Hytrin (Abbott)

$1.48 Terazosin Tab 2 mg; 500 tablets, (28 tablets) hydrochloride* bottle *This product will become fully subsidised.

The brand that won the tender (i.e. ApoTerazosin) is listed on the Pharmaceutical Schedule on 1 May 2009, which is one month after the date of notification. The existing brand (i.e. Hytrin) is reference priced (the same subsidy) to the tender winning brand two months after that (1 July 2009). Three months following reference pricing (1 October 2009),

month 1 month 2 month 3

the tender winning brand (Apo-Terazosin) becomes the sole subsidised brand and the other brand (Hytrin) will be delisted. Below is a pictogram of timelines for the implementing of the terazosin hydrochloride 2 mg tablet tender process. It clearly shows the milestones for each of the processes.

month 4

month 5

month 6

month 7

month 8

✰

last day of the month notification fax sent

●

Listing for tender winning brand

✰

Tender winning brand Sole Subsidised Supply from first day of month 7

▲

●

Reference pricing of non-tender winning brand

● ✰

non-tender winning brand subsidised until the last day of month 6

Example

(March) (April) (May) (June)

2009 (July) (August) (September) (October) (November)

✰

31 March notification fax sent

●

Apo-Terazosin brand subsidised

✰

Apo-Terazosin sole subsidised Supply from 1 October 2009

▲

●

Hytrin reference priced to Apo-Terazosin Hytrin delisted 30 September 2009

● ✰

6 Pharmaceutical Schedule - Update News

For all changes (price change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H) pharmaceutical suppliers are required to notify PHARMAC and the Pharmacy Guild by 4 pm on the 12th of the month prior to the change. This notification confirms listing information, price and the product’s pharmacode. More information and product notification forms can be downloaded from PHARMAC’s website – www.pharmac.govt.nz/ suppliers. Sometimes the listing dates can change from what was originally notified. At times we will delay listing a product for registration

purposes or until we are certain there is sufficient stock in the market. Any change will be reflected in future Schedule Updates and notification facsimiles.

Pilocarpine eye drops

Sigma Pharmaceuticals have advised that they are no longer going to supply pilocarpine eyedrops (Pilopt); The stock of each formulation will run out as follows: Pilopt 1% August 2009 Pilopt 2% May/June 2009 Pilopt 4% July 2009 Pilopt 6% May/June 2009 PHARMAC staff have been actively seeking alternative supply for several months and will provide an update on any information when it becomes available

Metoprolol succinate tablets

AFT’s brand of metoprolol succinate long-acting tablets (Metoprolol-AFT CR) will be listed on the Pharmaceutical Schedule from 1 June 2009. It will be fully funded for all patients. The current endorsement criteria that applies to metoprolol succinate will not apply to Metoprolol-AFT CR however they will continue to apply to Betaloc CR.

Pharmaceutical Schedule - Update News

Hydrocortisone powder tender

As a result of a tender agreement, ABM’s brand of hydrocortisone powder will be listed on the Pharmaceutical Schedule from 1 June 2009 and will become the sole subsidised brand of hydrocortisone powder from 1 November 2009. The change to sole supply will include reduced subsidies for m-Hydrocortisone from 1 August 2009, and delisting of this brand from 1 November 2009.

Consultation on the draft revised Funding Application Guidelines (Version 2)

PHARMAC is inviting submissions on a revised version of the Funding Application Guidelines. The Application Guidelines are intended for anyone wanting to make a funding Application. The aims of this revision include: the Prescription for Pharmacoeconomic Analysis (PFPA) (http://www.pharmac.govt. nz/2007/06/19/PFPAFinal.pdf ); understanding of the application process; and all the information that PHARMAC requires in the application process. The draft revised Funding Application Guidelines are available on the Consultation page of the PHARMAC website at http:// www.pharmac.govt.nz/consultation, under the heading ‘Draft version 2 of the Funding Application Guidelines. Closes 1 July 2009’. We invite you to send a submission to PHARMAC regarding your views on the draft version 2 of the Funding Application Guidelines by way of written submission to guidelines@pharmac.govt.nz. The deadline for response is 1 July 2009.

Diltiazem changes

From 1 June, the Dilzem SR and LA brands of diltiazem hydrochloride will be delisted from the Pharmaceutical Schedule. If you have any patients that are still using these brands then they will need to be switched to the appropriate alternative. For further information regarding the alternatives please refer to the February Pharmaceutical Schedule Update or the clinical advice on the PHARMAC website (under the notification section)

Looking Forward

This section is designed to alert both pharmacists and prescribers to possible future changes. It may assist pharmacists to manage stock levels and keep prescribers up-to-date with proposals to change the Pharmaceutical Schedule. Possible decisions for implementation 1 July 2009

Sole Subsidised Supply Products – cumulative to June 2009

Generic Name

Acetazolamide Aciclovir Allopurinol Alprazolam

Presentation

Tab 250 mg; 100 tab Tab dispersible 200 mg Tab dispersible 400 mg Tab 100 mg; 250 Tab 300 mg; 100 Tab 250 μg Tab 500 μg Tab 1 mg Inj 10 mg per ml, 1 ml Cap 100 mg Tab 5 mg Tab 10 mg Drops 100 mg per ml; 30 ml OP Inj 250 mg; 10 pack Inj 500 mg; 10 pack Inj 1 g; 10 pack Cap 250 mg & 500 mg Grans for oral liq 125 mg per 5 ml Grans for oral liq 250 mg per 5 ml Crm 500 g; pot Tab 100 mg Tab dispersible 300 mg Tab 100 mg Tab 50 mg & 100 mg Eye drops 1%; 15 ml OP Inj 600 μg, 1 ml Inj 1200 μg, 1 ml Tab 500 mg Metered aqueous nasal spray 50 μg Metered aqueous nasal spray 100 μg Inj 1 mega u; 10 inj Scalp app 0.1% Tab 200 mg; 90 tab Tab 50 mg Tab 5 mg Eye drops 0.2% Inj 0.5%, 4 ml Inj 0.5%, 8% glucose, 4 ml Lotion BP Crm, aqueous, BP

Brand Name Expiry Date*

Diamox Lovir Lovir Apo-Allopurinol Arrow-Alprazolam Arrow-Alprazolam Arrow-Alprazolam Mayne Symmetrel Apo-Amlodipine Ospamox Ibiamox Apo-Amoxi Ranbaxy Amoxicillin Ranbaxy Amoxicillin AFT Apo-Ascorbic Acid Ethics Aspirin Ethics Aspirin EC Loten Atropt AstraZeneca AstraZeneca Arrow-Azithromycin Alanase Alanase Sandoz Beta Scalp Fibalip Bicalox Lax-Tab AFT Marcain Isobaric Marcain Heavy ABM ABM 2009 2010 2009 2011 2009 2009 2009 2011 2009 2011 2011 2010 2011 2010 2009 2011 2009 2011 2010

Apomorphine hydrochloride Amantadine hydrochloride Amlodipine Amoxycillin

2009 2011 2011 2011

2010 2009

Aqueous cream Ascorbic acid Aspirin Atenolol Atropine sulphate

Azithromycin Beclomethasone dipropionate Benzylpenicillin sodium (Penicillin G) Betamethasone valerate Bezaﬁbrate Bicalutamide Bisacodyl Brimonidine tartrate Bupivicaine hydrochloride Calamine

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 9

Sole Subsidised Supply Products – cumulative to June 2009

Generic Name

Calcitonin Calcitriol Calcium Calcium folinate Captopril Cefaclor monohydrate Cefazolin sodium Cefuroxime sodium Cetomacrogol Cetirizine hydrochloride Chloramphenicol Chlorhexidine gluconate

Presentation

Inj 100 iu per ml, 1 ml; 5 inj Cap 0.25 μg & 0.5 μg Tab eff 1 g; 30 tab Inj 50 mg Tab 12.5 mg, 25 mg & 50 mg Cap 250 mg Grans for oral liq 125 mg per 5 ml Inj 500 mg Inj 1 g Inj 750 mg & 1.5 g Crm BP Tab 10 mg Oral liq 1 mg per ml; 200 ml Eye drops 0.5% Eye oint 1% Soln 4% Handrub 1% with ethanol 70% Mouthwash 0.2% Tab 25 mg Tab 250 mg Tab 500 mg Tab 750 mg Tab 20 mg; 84 pack Tab 250 mg Grans for oral liq 125 mg per 5 ml Crm 0.05% Tab 500 μg; 100 tab Tab 2 mg; 100 tab Vaginal crm 2%; 20 g OP Crm 1% Vaginal crm 1% with applicator(s) Tab 15 mg, 30 mg & 60 mg Tab 500 μg Sach 5 g Inj 150 mg Powder for soln for oral use Tab 50 mg Tab 50 mg Tab 50 mg

Brand Name Expiry Date*

Miacalcic Calcitriol-AFT Calsource Calcium Folinate Ebewe Apo-Captopril Ranbaxy Cefaclor Ranbaxy Cefaclor Hospira Zinacef PSM Zetop Cetirizine-AFT Chlorsig Chlorsig Orion Orion Orion Hygroton Rex Medical 2011 2009 2011 2011 2010 2010 2011 2011 2010 2011 2009 2011 2009 2009 2011

Chlorthalidone Ciproﬂoxacin

Citalopram Clarithromycin Clobetasol propionate Clonazepam Clotrimazole

Arrow-Citalopram Klamycin Klacid Dermol Paxam Paxam Clomazol Clomazol Clomazol PSM Colgout Colestid Colistin-Link Enerlyte Nausicalm Cycloblastin Siterone

2010 2010 2009 2011 2010

Codeine phosphate Colchicine Colestipol hydrochloride Colistin sulphomethate Compound electrolytes Cyclizine hydrochloride Cyclophosphamide Cyproterone acetate

2010 2010 2010 2010 2010 2009 2010 2009

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 10

Sole Subsidised Supply Products – cumulative to June 2009

Generic Name

Dantrolene sodium Desferrioxamine mesylate Desmopressin Dexamethasone sodium phosphate Dexamphetamine sulphate Dextrose Dextrose with electrolytes

Presentation

Cap 25 mg & 50 mg Inj 500 mg Nasal spray 10 mcg per dose Inj 4 mg per ml, 1 ml Inj 4 mg per ml, 2 ml Tab 5 mg Inj 50%, 10 ml Oral soln with electrolytes

Brand Name Expiry Date*

Dantrium Mayne Desmopressin-PH&T Mayne PSM Biomed Pedialyte – Plain Pedialyte – Bubblegum Pedialyte – Fruit Voltaren Ophtha Voltaren Voltaren Voltaren Voltaren Voltaren Apo-Diclo Apo-Diclo SR Videx EC Dilzem Cardizem CD 2009 2010 2011 2009 2010 2011 2010

Diclofenac sodium

Eye drops 1 mg per ml Inj 25 mg per ml, 3 ml Suppos 12.5 mg Suppos 25 mg Suppos 50 mg Suppos 100 mg Tab EC 25 mg & 50 mg Tab long-acting 75 mg & 100 mg Cap 125 mg, 200 mg, 250 mg & 400 mg Tab 30 mg; 100 Tab 60 mg; 100 Cap long-acting 120 mg; 30 Cap long-acting 180 mg; 30 Cap long-acting 240 mg; 30 Tab long-acting 150 mg Tab 2 mg & 4 mg Oint BP Tab 5 mg, 10 mg & 20 mg Inj 500 μg per ml, 1 ml Tab 1 mg with caffeine 100 mg Grans for oral liq 200 mg per 5 ml; 100 ml Grans for oral liq 400 mg per 5 ml; 100 ml Tab 10 μg Tab 35 μg with norethisterone 500 μg Tab 35 μg with norethisterone 1 mg Tab 35 μg with norethisterone 1 mg and 7 inert tab Cap 50 mg & 100 mg

2011

2009 2009 2011

Didanosine (DDI) Diltiazem hydrochloride

Dipyridamole Doxazosin mesylate Emulsifying ointment Enalapril Ergometrine maleate Ergotamine tartrate with caffeine Erythromycin ethyl succinate

Pytazen SR Apo-Doxazosin AFT m-Enalapril Mayne Cafergot E-Mycin E-Mycin New Zealand Medical and Scientiﬁc Brevinor 21 Brevinor 1/21 Brevinor 1/28 Vepesid

2011 2010 2011 2009 2009 2009 2011

Ethinyloestradiol Ethinyloestradiol with norethisterone

2009 2010

Etoposide

2009

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 11

Sole Subsidised Supply Products – cumulative to June 2009

Generic Name

Ferrous sulphate Finasteride Flucloxacillin

Presentation

Oral liq 150 mg per 5 ml Tab 5 mg; 30 tab Inj 250 mg; 10 pack Inj 500 mg; 10 pack Inj 1 g; 10 pack Cap 250 mg & 500 mg Grans for oral liq 125 mg per 5 ml Grans for oral liq 250 mg per 5 ml Cap 50 mg Cap 150 mg Cap 200 mg Inj 50 mg Tab 10 mg Oint 950 μg, with ﬂuocortolone pivalate 920 μg, and cinchocaine hydrochloride 5 mg per g Suppos 630 μg, with ﬂuocortolone pivalate 610 μg, and cinchocaine hydrochloride 1 mg Eye drops 0.1% Cap 20 mg Tab disp 20 mg, scored Tab 0.8 mg & 5 mg Crm 2% & Oint 2% Inj 40 mg per ml, 2 ml Tab 80 mg Tab 5 mg Tab 600 μg Oral pump spray 400 μg per dose TDDS 5 mg TDDS 10 mg Oral liq 2 mg per ml Tab 500 μg, 1.5 mg & 5 mg Inj 5 mg per ml, 1 ml Inj 10 iu per ml, 5 ml Crm 1% Tab 5 mg & 20 mg Rectal foam 10%, CFC-Free Scalp lotn 0.1% Lotn 1% with wool fat hydrous 3% and mineral oil Eye drops 0.5%

Brand Name Expiry Date*

Ferodan Fintral Flucloxin 2010 2011 2011

Flucloxacillin sodium

Staphlex AFT AFT Paciﬁc Paciﬁc Paciﬁc Fludara Fludara Ultraproct Ultraproct

2009

Fluconazole

2011

Fludarabine phosphate Fluocortolone caproate with ﬂuocortolone pivalate and cinchocaine

2011 2010

Fluorometholone Fluoxetine hydrochloride Folic Acid Fusidic acid Gentamicin sulphate Gliclazide Glipizide Glyceryl trinitrate

Flucon Fluox Fluox Apo-Folic Acid Foban Pﬁzer Apo-Gliclazide Minidiab Lycinate Nitrolingual pumpspray Nitroderm TTS 5 Nitroderm TTS 10 Serenace Serenace Serenace AstraZeneca PSM Douglas Colifoam Locoid DP Lotn HC Methopt

2009 2010 2009 2010 2009 2011 2011 2011

Haloperidol

2010 2009 2009 2011 2009 2009 2010 2011 2011

Heparinised saline Hydrocortisone Hydrocortisone acetate Hydrcortisone butyrate Hydrocortisone with wool fat and mineral oil Hypromellose

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 12

Sole Subsidised Supply Products – cumulative to June 2009

Generic Name

Hysocine N-butylbromide Ibuprofen Imipramine hydrochloride Indapamide Ipratropium bromide

Presentation

Inj 20 mg, 1 ml Tab 20 mg Oral liq 100 mg per 5 ml, 200 ml Tab 10 mg & 25 mg Tab 2.5 mg Aqueous nasal spray, 0.03% Nebuliser soln, 250 μg per ml, 1 ml Nebuliser soln, 250 μg per ml, 2 ml Inj 50 mg per ml, 2 ml Tab long-acting 60 mg Cap 10 mg Cap 20 mg Cap 100 mg Shampoo 2%, 100 ml OP Oral liq 10 g per 15 ml Eye drops 0.25% & 0.5% Cap 50 mg with benserazide 12.5 mg Tab dispersible 50 mg with benserazide 12.5 mg Cap 100 mg with benserazide 25 mg Cap long-acting 100 mg with benserazide 25 mg Cap 200 mg with benserazide 50 mg Inj 0.5%, 5 ml Inj 1%, 5 ml Inj 1%, 20 ml Crm 2.5% with prilocaine 2.5%; 30 g OP Crm 2.5% with prilocaine 2.5%; 5 g Tab 5 mg, 10 mg & 20 mg Tab 2 mg Tab 10 mg Oral liq 1 mg per ml

Brand Name Expiry Date*

Buscopan Gastrosoothe Fenpaed Tofranil Napamide Apo-Ipravent Ipratripium Steri-Neb Ipratripium Steri-Neb Ferrum H Duride Isotane 10 Isotane 20 Sporanox Sebizole Duphalac Betagan Madopar 62.5 Madopar Dispersible Madopar 125 Madopar HBS Madopar 250 Xylocaine Xylocaine Xylocaine EMLA EMLA Arrow-Lisinopril Nodia Loraclear Hayfever Relief Lorapaed Ativan Mayne Derbac M A-Lices Ludiomil Foremount Child’s Silicone Mask 2009 2010 2010 2010 2011 2010 2009 2009 2010

Iron polymaltose Isosorbide mononitrate Isotretinoin Itraconazole Ketoconazole Lactulose Levobunolol Levodopa with benserazide

2011 2009 2009 2010 2011 2010 2010 2009

Lignocaine hydrochloride

Lignocaine with prilocaine

2010

Lisinopril Loperamide hydrochloride Loratadine

Lorazepam Magnesium sulphate Malathion Maldison Maprotiline hydrochloride Mask for Spacer Device

Tab 1 mg & 2.5 mg Inj 49.3% Liq 0.5% Shampoo 1% Tab 25 mg & 75 mg Device

2009 2009 2010 2010 2009 2011

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 13

Sole Subsidised Supply Products – cumulative to June 2009

Generic Name

Mebeverine hydrochloride Medroxyprogesterone acetate Mesalazine Metformin hydrochloride Methadone hydrochloride Methotrexate

Presentation

Tab 135 mg; 90 tab Tab 2.5 mg, 5 mg, 10 mg, 100 mg & 200 mg Enema 1 g per 100 ml Tab 500 mg & 850 mg Tab 5 mg Powder 1 g Inj 100 mg per ml, 10 ml Inj 100 mg per ml, 50 ml Tab 2.5 mg & 10 mg Tab 125 mg; 100 tab Tab 250 mg; 100 tab Tab 500 mg; 100 tab Tab long-acting 20 mg Tab 5 mg & 20 mg Tab 10 mg Tab 4 mg & 100 mg Crm 0.1% and oint 0.1% Inj 40 mg per ml, 1 ml Inj 40 mg per ml with lignocaine 1 ml Inj 40 mg per ml, 1 ml Inj 62.5 mg per ml, 1 ml Inj 500 mg & 1 g Inj 5 mg per ml, 2 ml Tab long-acting 200 mg Cap 250 mg Crm 2% Tab 2.5 mg & 5 mg Tab 200 μg Tab 150 mg & 300 mg Oral liq 1 mg per ml Oral liq 2 mg per ml Oral liq 5 mg per ml Oral liq 10 mg per ml

Brand Name Expiry Date*

Colofac Provera Pentasa Arrow-Metformin Methatabs AFT Methotrexate Ebewe Methotrexate Ebewe Methoblastin Prodopa Prodopa Prodopa Rubifen SR Rubifen Rubifen Medrol Advantan Depo-Medrol Depo-Medrol with Lidocaine Solu-Medrol Solu-Medrol Solu-Medrol Pﬁzer Slow-Lopresor Metopirone Multichem Gutron Cytotec Apo-Moclobemide RA-Morph RA-Morph RA-Morph RA-Morph 2011 2010 2009 2009 2010 2009 2011 2009 2011

Methyldopa

Methylphenidate hydrochloride

2009

Methylprednisolone Methylprednisolone aceponate Methylprednisolone acetate Methylprednisolone acetate with lignocaine Methylprednisolone sodium succinate Metoclopramide hydrochloride Metoprolol tartrate Metyrapone Miconazole nitrate Midodrine Misoprostol Moclobemide Morphine hydrochloride

2009 2009 2011 2011 2009

2011 2009 2009 2011 2009 2009 2009 2009

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 14

Sole Subsidised Supply Products – cumulative to June 2009

Generic Name

Morphine sulphate

Presentation

Inj 10 mg per ml, 1 ml Inj 30 mg per ml, 1 ml Inj 5 mg per ml, 1 ml Inj 15 mg per ml, 1 ml Cap long-acting 10 mg, 30 mg, 60 mg, 100 mg & 200 mg Tab immediate release 10 mg & 20 mg Inj 80 mg per ml, 1.5 ml & 5 ml Tab 40 mg & 80 mg Tab 50 mg Tab 250 mg Tab 500 mg Tab 275 mg Inj 2.5 mg per ml, 1 ml Oral suspension 10 mg per ml Patch 7 mg, 14 mg and 21 mg Lozenge 1 mg and 2 mg Gum 2 mg (Fruit) Gum 2 mg (Mint) Gum 4 mg (Fruit) Gum 4 mg (Mint) Tab 50 mg & 500 mg Tab long-acting 20 mg Tab 5 mg Tab 350 μg Tab 10 mg; 100 tab Tab 25 mg; 250 tab Oral liq 100,000 u per ml, 24 ml OP Cap 500,000 u Tab 500,000 u Vaginal crm 100,000 u per 5 g with applicators Cap 10 mg; 28 and 30 Cap 20 mg; 28 and 30 Cap 40 mg; 28 and 30 Inj 40 mg; 5 Tab 4 mg & 8 mg Tab disp 4 mg & 8 mg Tab 5 mg Oral liq 5 mg per 5 ml Inj 10 mg per ml, 1 ml and 2 ml Oral liq 5 mg per 5 ml

Brand Name Expiry Date*

Mayne Mayne Mayne Mayne m-Eslon Sevredol Mayne Apo-Nadolol ReVia Noﬂam 250 Noﬂam 500 Sonaﬂam AstraZeneca Viramune Suspension Habitrol Habitrol Habitrol Habitrol Habitrol Habitrol Apo-Nicotinic Acid Nyefax Retard Primolut N Noriday 28 Norpress Norpress Nilstat Nilstat Nilstat Nilstat Dr Reddy’s Omeprazole 2009 2010 2010 2009 2010 2010 2009 2010 2011 2009

Morphine tartrate Nadolol Naltrexone hydrochloride Naproxen Naproxen sodium Neostigmine Nevirapine Nicotine

Nicotinic acid Nifedipine Norethisterone Nortriptyline hydrochloride Nystatin

2009 2009 2011 2009 2011 2011 2010 2009 2011

Omeprazole

Ondansetron Oxybutynin Oxycodone hydrochloride

Zofran Zofran Zydis Apo-Oxybutynin Apo-Oxybutynin OxyNorm OxyNorm

2010 2010 2010

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 15

Sole Subsidised Supply Products – cumulative to June 2009

Generic Name

Oxytocin

Presentation

Inj 5 iu per ml, 1 ml Inj 10 iu per ml, 1 ml Inj 5 iu with ergometrine maleate 500 μg per ml, 1 ml Inj 3 mg per ml, 5 ml Inj 3 mg per ml, 10 ml Inj 6 mg per ml, 10 ml Inj 40 mg; 1 inj Tab 20 mg Tab 40 mg

Brand Name Expiry Date*

Syntocinon Syntocinon Syntometrine Pamisol Pamisol Pamisol Pantocid IV Dr Reddy’s Pantoprazole Dr Reddy’s Pantoprazole Pharmacare Paracetamol Paracare Junior Paracare Double Strength Lacri-Lube Loxamine Breath-Alert Permax Permax Pexsig AFT AFT Cilicaine VK Cilicaine VK Prefrin Coloxyl Vistil Vistil Forte Span-K Apo-Prazo Apo-Prednisone Apo-Prednisone Apo-Prednisone Apo-Prednisone MDS Quick Card Cilicaine Allersoothe Apo-Pyridoxine 2009

Pamidronate disodium

2011

Pantoprazole

2010

Paracetamol

Tab 500 mg; 1,000 Oral liq 120 mg per 5 ml Oral liq 250 mg per 5 ml

2011

Parafﬁn liquid with soft white parafﬁn Paroxetine hydrochloride Peak Flow Meter Pergolide Perhexiline maleate Phenoxymethylpenicillin (Penicillin V)

Eye oint with soft white parafﬁn Tab 20 mg Low range Tab 0.25 mg Tab 1 mg Tab 100 mg Grans for oral liq 125 mg per 5 ml Grans for oral liq 250 mg per 5 ml Cap potassium salt 250 mg Cap potassium salt 500 mg Eye drops 0.12% Oral drops 10%, 30 ml OP Eye drops 1.4% Eye drops 3% Tab long-acting 600 mg Tab 1 mg, 2 mg & 5 mg Tab 1 mg; 500 tab Tab 2.5 mg; 500 tab Tab 5 mg; 500 tab Tab 20 mg; 500 tab Cassette Inj 1.5 mega u; 5 inj Tab 10 mg Tab 25 mg Tab 50 mg

2010 2010 2011 2011 2009 2010

Phenylephrine hydrochloride Poloxamer Polyvinyl alcohol Potassium chloride Prazosin hydrochloride Prednisone

2010 2011 2011 2009 2010 2011

Pregnancy tests - HCG urine Procaine penicillin Promethazine Pyridoxine hydrochloride

2009 2011 2011 2009

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 16

Sole Subsidised Supply Products – cumulative to June 2009

Generic Name

Quinapril Quinapril with hydroclorothiazide

Presentation

Tab 5 mg; 10 mg & 20 mg Tab 10 mg with hydroclorothiazide 12.5 mg Tab 20 mg with hydroclorothiazide 12.5 mg Tab 200 mg Tab 300 mg Oral liq 150 mg per 10 ml Cap 150 mg Tab 150 mg & 300 mg Nebuliser soln 1 mg per ml, 2.5 ml Nebuliser soln 2 mg per ml, 2.5 ml Oral liq 2 mg per 5 ml Nebuliser soln, 2.5 mg with ipratropium bromide 0.5 mg Tab 5 mg Inj 0.9%, 5 ml & 10 ml Grans eff 4 g sachets Nasal spray 4% 230 ml Tab 500 mg Tab EC 500 mg Liq Soln 2.3%; 500 ml and 1,000 ml

Brand Name Expiry Date*

Accupril Accuretic 10 Accuretic 20 Q 200 Q 300 Peptisoothe Mycobutin Arrow-Roxithromycin Asthalin Asthalin Salapin Duolin Apo-Selegiline AstraZeneca Ural Rex Space Chamber Salazopyrin Salazopyrin EN Midwest Pinetarsol 2009 2010 2010 2009 2009 2010 2009 2009 2009 2010 2009 2011 2009 2010 2011 2011 2011

Quinine sulphate Ranitidine hydrochloride Rifabutin Roxithromycin Salbutamol

Salbutamol with ipratropium bromide Selegiline hydrochloride Sodium chloride Sodium citro-tartrate Sodium cromoglycate Spacer Device Sulphasalazine Syrup (pharmaceutical grade) Tar with triethanolamine lauryl sulphate and ﬂuorescein sodium Temazepam Terbinaﬁne Testosterone cypionate Tetracosactrin Timolol maleate

Tab 10 mg; 25 tab Tab 250 mg Inj long-acting 100 mg per ml, 10 ml Inj 250 mcg Inj 1 mg per ml, 1 ml Eye drops 0.25% Eye drops 0.5% Tab 10 mg Tab 50 mg Crm 0.02%; 100 g OP Oint 0.02%; 100 g OP Inj 40 mg per ml, 1 ml; 5 inj 0.1% in Dental Paste USP Ear drops 1 mg with nystatin 100,000 u, neomycin sulphate 2.5 mg and gramicidin 250 mcg per g

Normison Apo-Terbinaﬁne Depo-Testosterone Synacthen Synacthen Depot Apo-Timop Apo-Timop Apo-Timol Apo-Thiamine Aristocort Aristocort Kenacort-A40 Oracort Kenacomb

2011 2011 2011 2011 2011 2009 2009 2011 2011 2009

Thiamine hydrochloride Triamcinolone acetonide

Triamcinolone acetonide with gramicidin, neomycin and nystatin

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 17

Sole Subsidised Supply Products – cumulative to June 2009

Generic Name

Trimethoprim Ursodeoxycholic acid Vancomycin hydrochloride Vincristine sulphate Vitamins Vitamin B complex Water Zinc and castor oil Zinc sulphate Zopiclone June changes in bold type.

Presentation

Tab 300 mg; 50 tab Cap 300 mg Inj 50 mg per ml, 10 ml; 1 inj Inj 1 mg per ml, 1 ml Inj 1 mg per ml, 2 ml Tab (BPC cap strength) Tab, strong, BPC Puriﬁed for injection 20 ml Ointment BP Cap 220 mg; 100 cap Tab 7.5 mg

Brand Name Expiry Date*

TMP Actigall Paciﬁc Mayne Mayne Healtheries Apo-B-Complex Multichem PSM Zincaps Apo-Zopiclone 2011 2011 2011 2009 2009 2009 2009 2011 2011 2011

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 18

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr fully subsidised

30 53

GLIBENCLAMIDE Tab 5 mg .................................................................................. 5.00 METOPROLOL SUCCINATE Tab long-acting 23.75 mg ...................................................... 2.73 Tab long-acting 47.5 mg .......................................................... 3.41 Tab long-acting 95 mg ........................................................... 5.88 Tab long-acting 190 mg ....................................................... 10.63

100 30 30 30 30

✔ Daonil ✔ Metoprolol-AFT CR ✔ Metoprolol-AFT CR ✔ Metoprolol-AFT CR ✔ Metoprolol-AFT CR

Note – the endorsement requirement for full funding does not apply to the Metoprolol-AFT CR brand of metoprolol succinate long-acting tablets as they are listed fully subsidised. 61 104 163 HYDROCORTISONE Powder – Only in combination ................................................. 33.00 PAMIDRONATE DISODIUM Inj 9 mg per ml, 10 ml ........................................................... 112.50 ACETYLCYSTEINE – Hospital pharmacy [HP1]-Specialist Inj 200 mg per ml, 10 ml ....................................................... 137.06 (219.75) 25 g 1 10 Martindale Acetylcysteine ✔ ABM ✔ Pamisol

ATORVASTATIN – Additional subsidy by Special Authority see SA0788 below – Retail pharmacy See prescribing guideline on the preceding page Tab 80 mg .............................................................................. 16.28 30 (110.50) Lipitor TERAZOSIN HYDROCHLORIDE Tab 1 mg .................................................................................. 2.50 Tab 2 mg ................................................................................ 23.30 Tab 5 mg ................................................................................ 29.00 CO-TRIMOXAZOLE Oral liq trimethoprim 40 mg and sulphamethoxazole 200 mg per 5 ml – Up to 200 ml available on a PSO ........................................... 2.15 NORTRIPTYLINE HYDROCHLORIDE Tab 25 mg .............................................................................. 14.44 PACLITAXEL – PCT only – Specialist Inj 30 mg .............................................................................. 189.75 28 500 500 ✔ Apo-Terazosin ✔ Apo-Terazosin ✔ Apo-Terazosin

100 ml 180 5

✔ Deprim ✔ Norpress ✔ Paclitaxel Ebewe

110 138 172

Three months supply may be dispensed at one time if endorsed “certiﬁed exemption” by the prescriber.

Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr fully subsidised

172

PAEDIATRIC ORAL FEED WITH FIBRE 1.5KCAL/ML – Special Authority see SA0896 above – Hospital pharmacy [HP3] Liquid (strawberry) .................................................................... 1.60 200 ml OP ✔ NutriniDrink Multiﬁbre Liquid (chocolate) ..................................................................... 1.60 200 ml OP ✔ NutriniDrink Multiﬁbre Liquid (vanilla) .......................................................................... 1.60 200 ml OP ✔ NutriniDrink Multiﬁbre

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr fully subsidised

FRUSEMIDE FUROSEMIDE Tab 40 mg – Up to 30 tab available on a PSO .......................... 10.75 Tab 500 mg ............................................................................ 12.00 ‡ Oral liq 10 mg per ml............................................................. 10.66 Infusion ................................................................................. 481.40 Inj 10 mg per ml, 2 ml – Up to 5 inj available on a PSO ............ 29.50 CICLOPIROX OLAMINE CICLOPIROXOLAMINE a) Only on a prescription b) not in combination Nail soln 8% ........................................................................... 19.85

1,000 100 30 ml OP 5 50

✔ Diurin 40 ✔ Diurin 500 ✔ Lasix ✔ Lasix ✔ Mayne

3.5 ml OP ✔ Batrafen

Three months supply may be dispensed at one time if endorsed “certiﬁed exemption” by the prescriber.

Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr fully subsidised

DILTIAZEM HYDROCHLORIDE (ê subsidy and price) Cap 120 mg .............................................................................. 4.34 Cap 180 mg .............................................................................. 6.50 Cap 240 mg .............................................................................. 8.67 OESTROGENS – See prescribing guideline on the preceding page (è price) Conjugated, equine tab 300 μg .................................................. 3.01 (11.48) Conjugated, equine tab 625 μg .................................................. 4.12 (11.48)

30 30 30 28

✔ Cardizem CD ✔ Cardizem CD ✔ Cardizem CD

Premarin 28 Premarin

OESTROGENS WITH MEDROXYPROGESTERONE – See prescribing guideline on page 76 (è price) Tab Conjugated 625 μg conjugated equine with 2.5 mg medroxyprogesterone acetate tab (28) ................................... 5.40 28 OP (22.96) Premia 2.5 Continuous Tab Conjugated 625 μg conjugated equine with 5 mg medroxyprogesterone acetate tab (28) ................................... 5.40 28 OP (22.96) Premia 5 Continuous BENZATHINE BENZYLPENICILLIN (è price and subsidy) Inj 1.2 mega μ per 2 ml – Up to 5 inj available on a PSO ........ 315.00 ROPINIROLE HYDROCHLORIDE (ê subsidy) Tab 0.25 mg ........................................................................... 19.75 (31.50) Tab 0.25 mg x 42, 0.5 mg x 42, and 1 mg x 21 ....................... 21.92 (35.70) Tab 0.25 mg x 42, 1 mg x 42, and 2 mg x 63 .......................... 73.60 (122.11) Tab 1 mg ................................................................................ 40.32 (67.20) Tab 2 mg ................................................................................ 60.72 (101.21) Tab 5 mg ................................................................................ 90.00 (150.00) 10 210 Requip 105 OP Requip Starter Pack 147 OP Requip Follow-on Pack 84 Requip 84 Requip 84 Requip 1 1 1 ✔ Calcium Folinate Ebewe ✔ Calcium Folinate Ebewe ✔ Calcium Folinate Ebewe ✔ Baxter ✔ Biomed ✔ Bicillin LA

86 118

132

CALCIUM FOLINATE – PCT – Hospital pharmacy [HP3]-Specialist (ê price) Inj 100 mg – PCT only – Specialist ............................................ 9.75 Inj 300 mg – PCT only – Specialist ......................................... 30.00 Inj 1 g – PCT only – Specialist .............................................. 100.00

133

GEMCITABINE HYDROCHLORIDE (ê subsidy and price) Inj 1 mg for ECP ........................................................................ 0.26

1 mg

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr fully subsidised

CALCIUM CARBONATE WITH AMINOACETIC ACID Tab 420 mg with aminoacetic acid 180 mg - Higher subsidy of $6.30 per 100 with Endorsement ........................................... 3.00 100 (6.30) Titralac Additional subsidy by endorsement is available for pregnant women. The prescription must be endorsed accordingly ACARBOSE (ê subsidy and price) – Special Authority see SA0925 below – Retail pharmacy Tab 50 mg .............................................................................. 16.50 90 ✔ Glucobay Tab 100 mg ............................................................................ 26.70 90 ✔ Glucobay COPPER (è price) Tab Diagnostic – Not on a BSO .................................................. 5.02 (31.80) GLUCOSE OXIDASE (è price) Urine diagnostic test with peroxidase – Not on a BSO ................. 4.13 (8.65) 4.11 (6.26) GLUCOSE OXIDASE (è price) Urine diagnostic test with peroxidase, potassium iodide, sodium nitroprusside and aminoacetic acid – Not on a BSO ......................................................................... 4.53 (14.87) SODIUM NITROPRUSSIDE (è price) Urine diagnostic strip, buffered – Not on a BSO .......................... 3.40 (10.94) SIMVASTATIN (ê subsidy)– See prescribing guidelines on page 45 Tab 10 mg ................................................................................ 0.68 (11.37) Tab 20 mg ................................................................................ 1.00 (11.67) Tab 40 mg ................................................................................ 1.78 (12.41) Tab 80 mg ................................................................................ 3.88 (14.39) SIMVASTATIN (è subsidy)– See prescribing guidelines on page 45 Tab 80 mg ................................................................................ 3.88 FUROSEMIDE (ê subsidy and price) Tab 40 mg - Up to 30 tab available on a PSO ........................... 10.75 CICLOPIROXOLAMINE (ê subsidy and price) a) Only on a prescription b) not in combination Nail soln 8% ........................................................................... 19.85 36 OP Clinitest 50 strip OP Clinistix Diastix

50 strip OP Keto-Diastix 50 strip OP Ketostix 30 30 30 30 Lipex 30 1,000 ✔ SimvaRex ✔ Diurin 40 ✔ SimvaRex Lipex ✔ SimvaRex Lipex ✔ SimvaRex Lipex

47 55 59

3.5 ml OP ✔ Batrafen

Three months supply may be dispensed at one time if endorsed “certiﬁed exemption” by the prescriber.

Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr fully subsidised

85 86

ERYTHROMYCIN ETHYL SUCCINATE (ê subsidy and price) Tab 400 mg - Up to 30 tab available on a PSO ........................ 16.95 AMOXYCILLIN CLAVULANATE (ê subsidy) Tab amoxycillin 500 mg with potassium clavulanate 125 mg - Up to 30 tab available on a PSO ........................................... 5.02 (6.40) HYDROXYCHLOROQUINE SULPHATE (ê subsidy and price) Tab 200 mg ............................................................................ 22.50 IBUPROFEN (ê subsidy) Tab 200 mg .............................................................................. 1.60 (1.78)

100

✔ E-Mycin

20 Augmentin 100 100 I-Profen ✔ Plaquenil

88 99

108

METHADONE HYDROCHLORIDE (ê subsidy and price) a) Only on a controlled drug form b) No patient co-payment payable c) Extemporaneously compounded methadone will only be reimbursed at the rate of the cheapest form available (methadone powder, not methadone tablets) d) For methadone hydrochloride oral liquid refer, page 162 ‡ Oral liq 2 mg per ml ................................................................... 5.95 200 ml ✔ Biodone ‡ Oral liq 5 mg per ml ................................................................... 5.55 200 ml ✔ Biodone Forte ‡ Oral liq 10 mg per ml .................................................................. 8.95 200 ml ✔ Biodone Extra Forte ENTACAPONE (ê subsidy and price) Tab 200 mg .......................................................................... 116.00 LEVOCABASTINE (ê price) Eye drops 0.5 mg per ml ........................................................... 8.71 (10.34) 100 4 ml OP Livostin ✔ Comtan

117 154

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr fully subsidised

BENZATHINE BENZYLPENICILLIN Inj 1.2 mega u per 2 2.3 ml – Up to 5 inj available on a PSO... 200.00

✔ Bicillin LA

For the list of new Sole Subsidised Supply products effective 1 June 2009 refer to the bold entries in the cumulative Sole Subsidised Supply table pages 9-18.

Three months supply may be dispensed at one time if endorsed “certiﬁed exemption” by the prescriber.

Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr fully subsidised

DOXAZOSIN MESYLATE Tab 2 mg ................................................................................. 4.81 Note – the 500 tablet pack listed 1 November 2008 OESTRADIOL VALERATE – See prescribing guideline Tab 2 mg ................................................................................. 4.12 PARACETAMOL Tab 500 mg – Up to 30 tab available on a PSO .......................... 1.38 (14.67) PARACETAMOL Tab 500 mg ......................................................................... 137.81 (1,467.00)

100

Apo-Doxazosin

77 107

28 150

Progynova

Panadol 15,000 Panadol

107

continued... Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply

S29

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr fully subsidised

63 64

ETHINYLOESTRADIOL WITH LEVONORGESTREL Tab ........................................................................................... 9.45 OESTRADIOL WITH LEVONORGESTREL Tab 2 mg with 75 μg levonorgestrel and tab 2mg Oestradiol (48) .................................................................... 16.20

Triquilar ED

Nuvelle

MEBENDAZOLE Tab 100 mg .............................................................................. 2.53 (7.43)

4 Vermox

TERAZOSIN HYDROCHLORIDE Tab 2 mg .................................................................................. 1.48 (4.66) Tab 5 mg .................................................................................. 1.91 (5.60) AZATHIOPRINE – Retail pharmacy-Specialist Tab 50 mg .............................................................................. 25.00

28 Hytrin 28 Hytrin 100 Thioprine

142

172

PAEDIATRIC ORAL FEED 1.5KCAL/ML – Special Authority see SA0896 above – Hospital pharmacy [HP3] Liquid (strawberry) .................................................................... 1.60 200 ml OP Fortini Liquid (vanilla)........................................................................... 1.60 200 ml OP Fortini PAEDIATRIC ORAL FEED WITH FIBRE 1.5KCAL/ML – Special Authority see SA0896 above – Hospital pharmacy [HP3] Liquid (chocolate) ..................................................................... 1.60 200 ml OP Fortini Multiﬁbre Liquid (strawberry) .................................................................... 1.60 200 ml OP Fortini Multiﬁbre Liquid (vanilla)........................................................................... 1.60 200 ml OP Fortini Multiﬁbre

172

CALCIUM CARBONATE WITH AMINOACETIC ACID Tab 420 mg with aminoacetic acid 180 mg – Higher subsidy of $38.73 per 1000 with Endorsement ................................. 30.00 (38.73) OIL IN WATER EMULSION Crm........................................................................................... 2.80

1,000 Titralac 500g Lemnis Fatty Cream

Three months supply may be dispensed at one time if endorsed “certiﬁed exemption” by the prescriber.

Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr fully subsidised

WOOL FAT WITH MINERAL OIL – Only on a prescription Lotn hydrous 3% with mineral oil ............................................... 5.60 (9.54)

1,000 ml Hydroderm Lotion

EFAVIRENZ – Special Authority see SA0779 on the preceding page – Hospital pharmacy [HP1] Tab 50 mg ............................................................................ 158.33 30 Stocrin Tab 200 mg .......................................................................... 474.99 90 Stocrin INDOMETHACIN Cap 25 mg ................................................................................ 5.90 NORTRIPTYLINE HYDROCHLORIDE Tab 25 mg .............................................................................. 20.06 100 250 Rheumacin Norpress

100 110 176

ENTERAL FEED WITH FIBRE 1KCAL/ML – Special Authority see SA0702 on page 174 – Hospital pharmacy [HP3] Liquid ........................................................................................ 1.24 250 ml OP 5.29 1,000 ml OP PILOCARPINE Eye drops 0.5% ......................................................................... 3.19 15 ml OP

Fibresource Fibresource RTH Pilopt

156

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr fully subsidised

Discretionary Community Supply Pharmaceuticals 8.1 Discretionary Community Supply Pharmaceuticals are deemed to include every medicine, therapeutic medical device, or related product or related thing listed in Section H Part IV of the Schedule. 8.2 PHARMAC may, in its discretion, list any pharmaceutical that is not a Community Pharmaceutical as a Discretionary Community Supply Pharmaceutical, including a pharmaceutical that PHARMAC is made aware of by HPAC, the Exceptional Circumstances Panel, a DHB Hospital or relevant hospital personnel. 8.3 A DHB Hospital may use its discretion to purchase Discretionary Community Supply Pharmaceuticals for use in the community, provided that, if the patient being treated with a Discretionary Community Supply Pharmaceutical usually resides in a district other than that within the jurisdiction of the DHB initiating the treatment, then the DHB initiating the treatment must either agree to fund any on-going treatment required once the patient has returned to his/her usual DHB, or obtain written consent from the DHB or DHBs in which the patient will reside following the commencement of treatment. 8.4 The funding of a Discretionary Community Supply Pharmaceutical for use in the community will be sourced from the relevant DHBs own budget. For the avoidance of doubt, the Discretionary Community Supply Pharmaceutical is not a Community Pharmaceutical and funding is not available for Discretionary Community Supply Pharmaceuticals from the Pharmaceutical Budget. 8.5 Subject to rule 8.6, DHB Hospitals must not fund for use in the community, any pharmaceuticals that are not Discretionary Community Supply Pharmaceuticals unless they have been approved under Hospital Exceptional Circumstances. 8.6 DHB Hospitals may fund from their own budgets, any Pharmaceutical that is listed in Sections A-G of the Pharmaceutical Schedule without Hospital Exceptional Circumstances (HEC) approval provided that: (a) the condition for which that Pharmaceutical is supplied is consistent with any restrictions applying to that Pharmaceutical in Section A-G of the Pharmaceutical Schedule; and (ba) (i) up to 5 days treatment, or one original pack, (where inappropriate to provide less); or (ii) more than 5 days treatment, provided that the relevant DHB Hospital has a dispensing for discharge policy and the quantity supplied is in accordance with that policy; and (b) the Pharmaceutical is supplied consistent with any restrictions applying to that Pharmaceutical in Section A-G of the Pharmaceutical Schedule. Note dispensing for discharge as described in rule 8.6 is at the discretion of individual DHBs.

Three months supply may be dispensed at one time if endorsed “certiﬁed exemption” by the prescriber.

Three months or six months, as applicable, dispensed all-at-once

Contracted Pharmaceutical Description

Brand

Price ($) (ex man. excl. GST)

Per

DV Limit

DV Limit DV applies Pharmaceutical from

ACETYLCYSTEINE (new listing) Inj 200 mg per ml, 10 ml ................Martindale 219.75 Acetylcysteine BENZATHINE BENZYLPENICILLIN (è price) Inj 1.2 mega u per 2.3 ml................Bicillin LA DILTIAZEM HYDROCHLORIDE (ê price) Cap long-acting 120 mg .................Cardizem CD Cap long-acting 180 mg .................Cardizem CD Cap long-acting 240 mg .................Cardizem CD ERYTHROPOIETIN BETA (delisting) Inj 1,000 iu preﬁlled syringe ............Recormon Inj 2,000 iu preﬁlled syringe ............Recormon Inj 3,000 iu preﬁlled syringe ............Recormon Inj 4,000 iu preﬁlled syringe ............Recormon Inj 5,000 iu preﬁlled syringe ............Recormon Inj 6,000 iu preﬁlled syringe ............Recormon Inj 10,000 iu preﬁlled syringe ..........Recormon HYDROCORTISONE (new listing and HSS) Powder ..........................................ABM 315.00 4.34 6.50 8.67 48.68 120.18 166.87 193.13 243.26 291.92 760.20 33.00

10 30 30 30 6 6 6 6 6 6 6 25 g 1% Aug-09 Apo-Hydrocortisone m-Hydrocortisone Pharmacia 5% 5% 5% Jun-09 Jun-09 Jun-09 (B) Dilzem LA Dilzem LA

METOPROLOL SUCCINATE (new listing) Tab long-acting 23.75 mg ..............Metoprolol-AFT CR Tab long-acting 47.5 mg.................Metoprolol-AFT CR Tab long-acting 95 mg....................Metoprolol-AFT CR Tab long-acting 190 mg ...............Metoprolol-AFT CR

2.73 3.41 5.88 10.63

30 30 30 30

ROPINIROLE HYDROCHLORIDE (delisting) Tab 0.25 mg...................................Requip 31.50 Tab 0.25 mg x 42, 0.5 mg x 42, and 1 mg x 21 ...........................Requip Starter 35.70 Pack Tab 0.25 mg x 42, 1 mg x 42, and 2 mg x 63 ...........................Requip 122.11 Follow-on Pack Tab 1 mg .......................................Requip 67.20 Tab 2 mg........................................Requip 101.21 Tab 5 mg........................................Requip 150.00

210 105 OP 147 OP

Products with Hospital Supply Status (HSS) are in bold.

(B) – Subject only to part (b) of the deﬁnition of “DV Pharmaceutical”

Contracted Pharmaceutical Description

Brand

Price ($) (ex man. excl. GST)

Per

DV Limit

DV Limit DV applies Pharmaceutical from

ACARBOSE (new listing and HSS) Tab 50 mg......................................Glucobay Tab 100 mg....................................Glucobay CO-TRIMOXAZOLE (new listing) Oral liq 240 mg per 5 ml .................Deprim ENTACAPONE (new listing and HSS) Tab 200 mg....................................Comtan

16.50 26.70 2.15 116.00

90 90 100 ml 100 100

1% 1%

Jul-09 Jul-09

(B) (B)

1% 1% 1%

Jul-09 Jul-09 Jul-09

(B) (B) Apo-Frusemide Frusehexal Frusid (B)

ERYTHROMYCIN ETHYL SUCCINATE (ê price and HSS) Tab 400 mg ...................................E-Mycin 16.95

FRUSEMIDE FUROSEMIDE (Change in chemical name, ê price and HSS) Tab 40 mg......................................Diurin 40 10.75 1,000

HYDROXYCHLOROQUINE SULPHATE (ê price and HSS) Tab 200 mg....................................Plaquenil 22.50 LIGNOCAINE WITH PRILOCAINE (delisting) Patch 2.5% with prilocaine 2.5% .....EMLA 10.40

100 2 200 ml 200 ml 200 ml 30 30 30

Jul-09

METHADONE HYDROCHLORIDE (ê price and HSS) Oral liq 2 mg per ml ........................Biodone 5.95 Oral liq 5 mg per ml ........................Biodone Forte 5.55 Oral liq 10 mg per ml .....................Biodone Extra Forte8.95 OMEPRAZOLE (addition of HSS) Cap 10 mg .....................................Dr Reddy’s Omeprazole Cap 20 mg .....................................Dr Reddy’s Omeperazole Cap 40 mg .....................................Dr Reddy’s Omeprazole OMEPRAZOLE (delisting) Inf 40 mg .......................................Losec IV 2.14 3.05 3.59

1% 1% 1% 1% 1% 1%

Jul-09 Jul-09 Jul-09 May-09 May-09 May-09

(B) (B) (B) Losec Omezol Losec Omezol Losec Omezol

38.65

5 3.50 237 ml

SPECIAL FOOD SUPPLEMENT (new listing) Liquid, 237 ml ................................Impact Advanced Recovery Vanilla and Chocolate SPECIAL FOOD SUPPLEMENT (delisting) Powder, sachet 74 g.......................Oral Impact 17.50

AMIKACIN SULPHATE (delisting date) Inj 250 mg per ml, 2 ml ..................Amikin Note- This product will be delisted 1 July 2009 Products with Hospital Supply Status (HSS) are in bold.

15.00

Sept-06

(B)

(B) – Subject only to part (b) of the deﬁnition of “DV Pharmaceutical”

Contracted Pharmaceutical Description

Brand

Price ($) (ex man. excl. GST)

Per

DV Limit

DV Limit DV applies Pharmaceutical from

APOMORPHINE HYDROCHLORIDE (new listing) Inj 10 mg per ml, 2 ml ....................Apomine 50.43 5 Note – The Mayne brand of Apomorphine hydrochloride inj 10 mg per ml, 1 ml will be delisted from 1 October 2009. ATOMOXETINE HYDROCHLORIDE (new listing) Cap 10 mg .....................................Strattera Cap 18 mg .....................................Strattera Cap 25 mg .....................................Strattera Cap 40 mg .....................................Strattera Cap 60 mg .....................................Strattera Cap 80 mg .....................................Strattera Cap 100 mg ...................................Strattera CLOZAPINE (new listing) Tab 25 mg......................................Clozaril Tab 100 mg ...................................Clozaril 107.03 107.03 107.03 107.03 107.03 139.11 139.11 26.74 69.30 28 28 28 28 28 28 28 100 100

DANAZOL (new listing) Cap 100 mg ...................................Azol 56.66 100 Note - D Zol brand of Danazol cap 100 mg 30 pack size to be delisted 1 October 2009 DIAZEPAM (ê price) Rectal tubes 5 mg ..........................Stesolid Rectal tubes 10 mg ........................Stesolid 25.05 30.50 5 5 1 1 1% 1% Jun-09 Jun-09 Gemzar Hospira Gemzar Hospira Losec Losec IV

GEMCITABINE HYDROCHLORIDE (new listing and HSS) Inj 200 mg......................................Gemcitabine Ebewe49.00 Inj 1 g.............................................Gemcitabine Ebewe245.00 OMEPRAZOLE (addition of HSS) Inj 40 mg........................................Dr Reddy’s Omeprazole Inf 40 mg .......................................Dr Reddy’s Omeprazole PARACETAMOL (è price) Suppos 125 mg..............................Panadol Suppos 250 mg..............................Panadol

38.20 38.65

5 5

1% 1%

May-09 May-09

7.49 14.40

20 20

ROPINIROLE (new listing and HSS) Tab 0.25 mg ..................................Ropin 7.90 84 1% June-09 Requip Tab 1 mg .......................................Ropin 40.32 84 1% June-09 Requip Tab 2 mg .......................................Ropin 60.72 84 1% June-09 Requip Tab 5 mg .......................................Ropin 90.00 84 1% June-09 Requip Note – Requip tab 0.25mg, 1 mg, 2 mg and 5mg and Requip Starter pack and Follow-on pack will all be delisted 1 September 2009 VERAPAMIL (delisting) Tab 40 mg .....................................Verpamil Products with Hospital Supply Status (HSS) are in bold. 4.75 100 (B) – Subject only to part (b) of the deﬁnition of “DV Pharmaceutical”

Chemical and presentation

Brand

HYDRALAZINE Tab 25 mg S29 For patients with congestive heart failure: (1) who have not responded to treatment with ACE inhibitors and/or ARBs; or (2) in whom treatment with ACE inhibitors and/or ARBs is not tolerated due to renal impairment INDOMETHACIN Cap 25 mg S29 For any indication approved by the hospital service METOLAZONE S29 Tabs 5 mg For patients with congestive heart failure: (1) who have not responded to treatment with ACE inhibitors and/or ARBs; or (2) in whom treatment with ACE inhibitors and/or ARBs is not tolerated due to renal impairment L-ORNITHINE L-ASPARTATE (LOLA) S29 Sach 5 mg For patients with chronic hepatic encephalopathy who have not responded to treatment with lactulose

INDOMETHACIN Cap 50 mg S29 For any indication approved by the hospital service SPECIAL FOOD SUPPLEMENT (delisting) Powder, sachet 74 g Oral Impact Three sachets per day for 5-7 days prior to major gastrointestinal or head or neck surgery

Products with Hospital Supply Status (HSS) are in bold.

(B) – Subject only to part (b) of the deﬁnition of “DV Pharmaceutical”

Pharmaceuticals and brands A Acarbose ..................................................... 23, 31 Acetylcysteine.............................................. 19, 30 Amikacin sulphate .............................................. 31 Amikin ............................................................... 31 Amoxycillin clavulanate ...................................... 24 Apo-Doxazosin................................................... 26 Apomine ............................................................ 32 Apo-Terazosin.................................................... 19 Apomorphine hydrochloride ............................... 32 Atomoxetine hydrochloride ................................. 32 Atorvastatin........................................................ 19 Augmentin ......................................................... 24 Azathioprine ....................................................... 27 Azol ................................................................... 32 B Batrafen ............................................................. 21 Batrafen ............................................................. 23 Benzathine benzylpenicillin ..................... 22, 25, 30 Bicillin LA............................................... 22, 25, 30 Biodone ....................................................... 24, 31 Biodone Extra Forte ...................................... 24, 31 Biodone Forte............................................... 24, 31 C Calcium carbonate with aminoacetic acid ..... 23, 27 Calcium folinate ................................................. 22 Calcium Folinate Ebewe...................................... 22 Cardizem CD ................................................ 22, 30 Ciclopirox olamine.............................................. 21 Ciclopiroxolamine......................................... 21, 23 Clinistix .............................................................. 23 Clinitest.............................................................. 23 Clozapine ........................................................... 32 Clozaril .............................................................. 32 Co-trimoxazole ............................................. 19, 31 Comtan ........................................................ 24, 31 Copper............................................................... 23 D Daonil ................................................................ 19 Deprim......................................................... 19, 31 Diltiazem hydrochloride ................................ 22, 30 Diurin 40 ............................................................ 21 Doxazosin mesylate ........................................... 26 Dr Reddy’s Omeprazole................................ 31, 32 Danazol.............................................................. 32 Diastix ............................................................... 23 Diazepam........................................................... 32 Diurin 40 ...................................................... 23, 31 Diurin 500 .......................................................... 21 E Efavirenz ............................................................ 28 E-Mycin ....................................................... 24, 31 EMLA................................................................. 31 Entacapone .................................................. 24, 31 Enteral feed with ﬁbre 1kcal/ml ........................... 28 Erythromycin ethyl succinate ........................ 24, 31 Erythropoietin beta ............................................. 30 Ethinyloestradiol with levonorgestrel ................... 27 F Fibresource ........................................................ 28 Fibresource RTH ................................................ 28 Fortini ................................................................ 27 Fortini Multiﬁbre ................................................. 27 Frusemide .................................................... 21, 31 Furosemide ............................................ 21, 23, 31 G Gemcitabine Ebewe............................................ 32 Gemcitabine hydrochloride ........................... 22, 32 Glibenclamide .................................................... 19 Glucobay ..................................................... 23, 31 Glucose oxidase................................................. 23 H Hydralazine ........................................................ 33 Hydrocortisone ............................................ 19, 30 Hydroderm Lotion .............................................. 28 Hydroxychloroquine sulphate........................ 24, 31 Hytrin................................................................. 27 I Ibuprofen ........................................................... 24 Impact Advanced Recovery Vanilla and Chocolate 31 Indomethacin ..................................................... 33 I-Profen ............................................................. 24 Indomethacin ..................................................... 28 K Keto-Diastix ....................................................... 23 Ketostix.............................................................. 23 L Lasix .................................................................. 21 Lemnis Fatty Cream ........................................... 27 Levocabastine .................................................... 24 Lignocaine with prilocaine .................................. 31 Lipex.................................................................. 23 Lipitor ................................................................ 19 Livostin .............................................................. 24 L-ornithine l-aspartate (lola) ............................... 33 Losec IV ............................................................ 31 M Mebendazole...................................................... 27 Metolazone ........................................................ 33 Metoprolol-AFT CR....................................... 19, 30 Methadone hydrochloride ............................. 24, 31 Metoprolol succinate .................................... 19, 30 N Norpress ...................................................... 19, 28

Pharmaceuticals and brands Nortriptyline hydrochloride............................ 19, 28 NutriniDrink ........................................................ 19 NutriniDrink Multiﬁbre ......................................... 20 Nuvelle............................................................... 27 O Oestradiol valerate.............................................. 26 Oestradiol with levonorgestrel ............................. 27 Oestrogens ........................................................ 22 Oestrogens with medroxyprogesterone ............... 22 Oil in water emulsion .......................................... 27 Omeprazole........................................................ 31 Omeprazole (HSS) ............................................. 32 Oral Impact .................................................. 31, 33 P Paclitaxel ........................................................... 19 Paclitaxel Ebewe ................................................ 19 Paediatric oral feed 1.5kcal/ml...................... 19, 27 Paediatric oral feed with ﬁbre 1.5kcal/ml....... 20, 27 Pamidronate disodium ....................................... 19 Pamisol ............................................................. 19 Panadol ....................................................... 26, 32 Paracetamol................................................. 26, 32 Pilocarpine ......................................................... 28 Pilopt ................................................................. 28 Plaquenil ...................................................... 24, 31 Premarin ............................................................ 22 Premia 2.5 Continuous ....................................... 22 Premia 5 Continuous .......................................... 22 Progynova ......................................................... 26 R Recormon .......................................................... 30 Requip ......................................................... 22, 30 Requip Follow-on Pack................................. 22, 30 Requip Starter Pack...................................... 22, 30 Rheumacin ........................................................ 28 Ropin ................................................................. 32 Ropinirole .......................................................... 32 Ropinirole hydrochloride............................... 22, 30 S SimvaRex .......................................................... 23 Simvastatin ........................................................ 23 Sodium nitroprusside ......................................... 23 Special food supplement .............................. 31, 33 Stesolid ............................................................. 32 Stocrin ............................................................... 28 Strattera ............................................................. 32 T Terazosin hydrochloride ............................... 19, 27 Thioprine ........................................................... 27 Titralac ........................................................ 23, 27 Triquilar ED ........................................................ 27 V Verapamil .......................................................... 32 Vermox .............................................................. 27 Verpamil ............................................................ 32 W Wool fat with mineral oil ..................................... 28

Pharmaceutical Management Agency Level 9, Cigna House, 40 Mercer Street, PO Box 10-254, Wellington 6143, New Zealand Phone: 64 4 460 4990 - Fax: 64 4 460 4995 - www.pharmac.govt.nz Freephone Information line (9am-5pm weekdays) 0800 66 00 50

PHARMAC is the Government agency responsible for deciding which medicines are subsidised for New Zealanders. It manages spending on pharmaceuticals for the District Health Boards, and ensures that a comprehensive list of medicines (the Pharmaceutical Schedule) is subsidised for New Zealanders, and that the list of medicines continues to grow to meet the needs of patients.

Metadata

Title

Schedule Update - effective 1 June 2009

Abstract

Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 June 2009 Cumulative for May and June 2009. Section H cumulative for April, May and June 2009 Contents 2 Summary of PHARMAC decisions EFFECTIVE 1 JUNE 2009 New listings (page…

Page 1

Note

This text has been extracted from the source PDF document.

Also available as plain text.

Please contact webmaster to discuss alternative format options.